First Time Loading...
N

Nusantara Sejahtera Raya Tbk PT
IDX:CNMA

Watchlist Manager
Nusantara Sejahtera Raya Tbk PT
IDX:CNMA
Watchlist
Price: 210 IDR -0.94% Market Closed
Updated: May 22, 2024

Intrinsic Value

Nusantara Sejahtera Raya Tbk PT is a ID-based company operating in Entertainment industry. [ Read More ]

The intrinsic value of one CNMA stock under the Base Case scenario is 307.8 IDR. Compared to the current market price of 210 IDR, Nusantara Sejahtera Raya Tbk PT is Undervalued by 32%.

Key Points:
CNMA Intrinsic Value
Base Case
307.8 IDR
Undervaluation 32%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Nusantara Sejahtera Raya Tbk PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CNMA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Nusantara Sejahtera Raya Tbk PT

Provide an overview of the primary business activities
of Nusantara Sejahtera Raya Tbk PT.

What unique competitive advantages
does Nusantara Sejahtera Raya Tbk PT hold over its rivals?

What risks and challenges
does Nusantara Sejahtera Raya Tbk PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nusantara Sejahtera Raya Tbk PT.

Provide P/S
for Nusantara Sejahtera Raya Tbk PT.

Provide P/E
for Nusantara Sejahtera Raya Tbk PT.

Provide P/OCF
for Nusantara Sejahtera Raya Tbk PT.

Provide P/FCFE
for Nusantara Sejahtera Raya Tbk PT.

Provide P/B
for Nusantara Sejahtera Raya Tbk PT.

Provide EV/S
for Nusantara Sejahtera Raya Tbk PT.

Provide EV/GP
for Nusantara Sejahtera Raya Tbk PT.

Provide EV/EBITDA
for Nusantara Sejahtera Raya Tbk PT.

Provide EV/EBIT
for Nusantara Sejahtera Raya Tbk PT.

Provide EV/OCF
for Nusantara Sejahtera Raya Tbk PT.

Provide EV/FCFF
for Nusantara Sejahtera Raya Tbk PT.

Provide EV/IC
for Nusantara Sejahtera Raya Tbk PT.

Show me price targets
for Nusantara Sejahtera Raya Tbk PT made by professional analysts.

What are the Revenue projections
for Nusantara Sejahtera Raya Tbk PT?

How accurate were the past Revenue estimates
for Nusantara Sejahtera Raya Tbk PT?

What are the Net Income projections
for Nusantara Sejahtera Raya Tbk PT?

How accurate were the past Net Income estimates
for Nusantara Sejahtera Raya Tbk PT?

What are the EPS projections
for Nusantara Sejahtera Raya Tbk PT?

How accurate were the past EPS estimates
for Nusantara Sejahtera Raya Tbk PT?

What are the EBIT projections
for Nusantara Sejahtera Raya Tbk PT?

How accurate were the past EBIT estimates
for Nusantara Sejahtera Raya Tbk PT?

Compare the revenue forecasts
for Nusantara Sejahtera Raya Tbk PT with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nusantara Sejahtera Raya Tbk PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nusantara Sejahtera Raya Tbk PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nusantara Sejahtera Raya Tbk PT compared to its peers.

Compare the P/E ratios
of Nusantara Sejahtera Raya Tbk PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Nusantara Sejahtera Raya Tbk PT with its peers.

Analyze the financial leverage
of Nusantara Sejahtera Raya Tbk PT compared to its main competitors.

Show all profitability ratios
for Nusantara Sejahtera Raya Tbk PT.

Provide ROE
for Nusantara Sejahtera Raya Tbk PT.

Provide ROA
for Nusantara Sejahtera Raya Tbk PT.

Provide ROIC
for Nusantara Sejahtera Raya Tbk PT.

Provide ROCE
for Nusantara Sejahtera Raya Tbk PT.

Provide Gross Margin
for Nusantara Sejahtera Raya Tbk PT.

Provide Operating Margin
for Nusantara Sejahtera Raya Tbk PT.

Provide Net Margin
for Nusantara Sejahtera Raya Tbk PT.

Provide FCF Margin
for Nusantara Sejahtera Raya Tbk PT.

Show all solvency ratios
for Nusantara Sejahtera Raya Tbk PT.

Provide D/E Ratio
for Nusantara Sejahtera Raya Tbk PT.

Provide D/A Ratio
for Nusantara Sejahtera Raya Tbk PT.

Provide Interest Coverage Ratio
for Nusantara Sejahtera Raya Tbk PT.

Provide Altman Z-Score Ratio
for Nusantara Sejahtera Raya Tbk PT.

Provide Quick Ratio
for Nusantara Sejahtera Raya Tbk PT.

Provide Current Ratio
for Nusantara Sejahtera Raya Tbk PT.

Provide Cash Ratio
for Nusantara Sejahtera Raya Tbk PT.

What is the historical Revenue growth
over the last 5 years for Nusantara Sejahtera Raya Tbk PT?

What is the historical Net Income growth
over the last 5 years for Nusantara Sejahtera Raya Tbk PT?

What is the current Free Cash Flow
of Nusantara Sejahtera Raya Tbk PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nusantara Sejahtera Raya Tbk PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nusantara Sejahtera Raya Tbk PT

Current Assets 2.9T
Cash & Short-Term Investments 2.7T
Receivables 45.9B
Other Current Assets 158.6B
Non-Current Assets 4.7T
PP&E 4.5T
Intangibles 5.6B
Other Non-Current Assets 178.8B
Current Liabilities 720.6B
Accounts Payable 305.9B
Other Current Liabilities 414.7B
Non-Current Liabilities 1.9T
Long-Term Debt 1.6T
Other Non-Current Liabilities 330.6B
Efficiency

Earnings Waterfall
Nusantara Sejahtera Raya Tbk PT

Revenue
6.5T IDR
Operating Expenses
-5.3T IDR
Operating Income
1.2T IDR
Other Expenses
-417.7B IDR
Net Income
829.3B IDR

Free Cash Flow Analysis
Nusantara Sejahtera Raya Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CNMA Profitability Score
Profitability Due Diligence

Nusantara Sejahtera Raya Tbk PT's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROIC
Positive Free Cash Flow
Exceptional Revenue Growth Forecast
Positive 3-Year Average ROE
60/100
Profitability
Score

Nusantara Sejahtera Raya Tbk PT's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

CNMA Solvency Score
Solvency Due Diligence

Nusantara Sejahtera Raya Tbk PT's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
66/100
Solvency
Score

Nusantara Sejahtera Raya Tbk PT's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CNMA Price Targets Summary
Nusantara Sejahtera Raya Tbk PT

Wall Street analysts forecast CNMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNMA is 438.6 IDR with a low forecast of 434.3 IDR and a high forecast of 451.5 IDR.

Lowest
Price Target
434.3 IDR
107% Upside
Average
Price Target
438.6 IDR
109% Upside
Highest
Price Target
451.5 IDR
115% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Nusantara Sejahtera Raya Tbk PT

Shareholder Return

CNMA Price
Nusantara Sejahtera Raya Tbk PT

1M 1M
-1%
6M 6M
-23%
1Y 1Y
-34%
3Y 3Y
-34%
5Y 5Y
-34%
10Y 10Y
-34%
Annual Price Range
210
52w Low
210
52w High
316
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -34%
Shares Statistics
Market Capitalization 17.5T IDR
Shares Outstanding 83 345 000 000
Percentage of Shares Shorted
N/A

CNMA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Nusantara Sejahtera Raya Tbk PT

Country

Indonesia

Industry

Media

Market Cap

17.5T IDR

Dividend Yield

0%

Description

Nusantara Sejahtera Raya Tbk PT is a ID-based company operating in Entertainment industry. The company is headquartered in Jakarta Pusat, Dki Jakarta and currently employs 1,405 full-time employees. The company went IPO on 2023-08-02. PT Nusantara Sejahtera Raya Tbk is an Indonesia-based company, which is engaged in the movie screening industry and restaurants. The company is focused on operating movie theater chains under Cinema XXI. Cinema XXI has presented 1,244 screens in 233 cinema locations spread across 71 cities throughout Indonesia. The company owns and operates a cinema network with trademarks 21 and XXI located throughout Indonesia. Cinema XXI categorizes its business activities based on its main products, namely films/cinema, food and beverages, advertising, digital platforms and more. The cinema segment focuses on selling cinema tickets either through physical counters at cinemas or through the Cinema XXI online-based ticket sales system, namely m.tix and TIX.ID. Its digital platform offers transaction activity that generates rewards for services (convenience fee) from m.tix and TIX.ID. Its events and other business activities include services for events held at the XXI Ballroom, arcade games, vouchers, and movie cards.

Contact

DKI JAKARTA
Jakarta Pusat
Jl. Kh. Wahid Hasyim No.96-A, Kb. Sirih, Menteng

IPO

2023-08-02

Employees

1 405

Officers

President Director
Hans Gunadi M.Sc.
Finance & Accounting Director, Corporate Secretary and Director
Tri Rudy Anitio
Director & Operational Director
Arif Suherman
Head of Corporate Legal
Indah Tri Wahyuni

See Also

Discover More
What is the Intrinsic Value of one CNMA stock?

The intrinsic value of one CNMA stock under the Base Case scenario is 307.8 IDR.

Is CNMA stock undervalued or overvalued?

Compared to the current market price of 210 IDR, Nusantara Sejahtera Raya Tbk PT is Undervalued by 32%.